Homozygous Rapid Arylamine N-Acetyltransferase (NAT2) Genotype as a Susceptibility Factor for Lung Cancer

Ingolf Cascorbi; Jürgen Brockmöller; Przemyslaw M. Mrozikiewiz; Steffen Bauer; Robert Loddenkemper; Ivar Roots

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Epidemiology

Homozygous Rapid Arylamine N-Acetyltransferase (NAT2) Genotype as a Susceptibility Factor for Lung Cancer

Ingolf Cascorbi, Jürgen Brockmöller, Przemyslaw M. Mrozikiewiz, Steffen Bauer, Robert Loddenkemper and Ivar Roots

Ingolf Cascorbi

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jürgen Brockmöller

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Przemyslaw M. Mrozikiewiz

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steffen Bauer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Loddenkemper

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ivar Roots

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: Published September 1996

Article
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: March 2001 to January 2021

	Abstract	Full-text HTML	PDF
Total	1871	3	1278

Cited By

Article Information

Volume 56, Issue 17, pp. 3961-3966

PubMed

8752164

Published By

American Association for Cancer Research

Print ISSN

0008-5472

Online ISSN

1538-7445

History

Received February 14, 1996
Accepted July 2, 1996
Published first September 1, 1996.

Author Information

Ingolf Cascorbi²,
Jürgen Brockmöller,
Przemyslaw M. Mrozikiewiz,
Steffen Bauer,
Robert Loddenkemper, and
Ivar Roots

Institute of Clinical Pharmacology, University Clinic Charité, Humboldt University of Berlin, Schumannstrasse 20/21, D-10098 Berlin [I. C., J. B., P. M. M., S. B., I. R.], and Department of Pneumology, Lungenklinik Heckeshorn, D-14109 Berlin [R. L.], Germany

PreviousNext

September 1996
Volume 56, Issue 17

Table of Contents
Table of Contents (PDF)
Back Matter (PDF)
Editorial Board (PDF)
Front Matter (PDF)

Search for this keyword

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Homozygous Rapid Arylamine N-Acetyltransferase (NAT2) Genotype as a Susceptibility Factor for Lung Cancer

Message Subject (Your Name) has forwarded a page to you from Cancer Research

Message Body (Your Name) thought you would be interested in this article in Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Homozygous Rapid Arylamine N-Acetyltransferase (NAT2) Genotype as a Susceptibility Factor for Lung Cancer

Ingolf Cascorbi, Jürgen Brockmöller, Przemyslaw M. Mrozikiewiz, Steffen Bauer, Robert Loddenkemper and Ivar Roots

Cancer Res September 1 1996 (56) (17) 3961-3966;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Homozygous Rapid Arylamine N-Acetyltransferase (NAT2) Genotype as a Susceptibility Factor for Lung Cancer

Ingolf Cascorbi, Jürgen Brockmöller, Przemyslaw M. Mrozikiewiz, Steffen Bauer, Robert Loddenkemper and Ivar Roots

Cancer Res September 1 1996 (56) (17) 3961-3966;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
PDF

Cited By...

Epidemiology

Abstract 4634: Breastfeeding and prognosis of breast cancer among Chinese women
Abstract 6487: Circulating tumor cells, tumor- and endothelium- derived extracellular vesicles, but not circulating endothelial cells associate with poor prognosis in colorectal cancer
Abstract 6483: Performance characteristics of the first FDA-cleared droplet digital PCR (ddPCR) IVD assay for monitoring chronic myelogenous leukemia

Show more Epidemiology

Articles

Introduction of H. Robert Horvitz
Intersections between Blood Cell Development and Leukemia Genes
Genetic Control of Programmed Cell Death in the Nematode Caenorhabditis elegans

Show more Articles

Home
Alerts
Feedback
Privacy Policy

Articles

Online First
Current Issue
Past Issues
Meeting Abstracts

Info for

Authors
Subscribers
Advertisers
Librarians

About Cancer Research

About the Journal
Editorial Board
Permissions
Submit a Manuscript

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Main menu

User menu

Search

Homozygous Rapid Arylamine N-Acetyltransferase (NAT2) Genotype as a Susceptibility Factor for Lung Cancer

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: March 2001 to January 2021

Cited By

Article Information

Author Information

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Epidemiology

Articles

Articles

Info for

About Cancer Research